Affinage

PDE6G

Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma · UniProt P18545

Length
87 aa
Mass
9.6 kDa
Annotated
2026-04-29
53 papers in source corpus 16 papers cited in narrative 16 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

PDE6G encodes the inhibitory γ-subunit of rod photoreceptor cGMP-phosphodiesterase (PDE6), a central effector of the vertebrate phototransduction cascade that controls cGMP hydrolysis in response to light. PDE6γ suppresses basal catalytic activity of the PDE6αβ dimer, with C-terminal residues Ile86/Ile87 required for proper inhibitory control and Tyr84 essential for transducin-mediated activation of PDE6 (PMID:21920434, PMID:11171042); loss of the last seven C-terminal residues abolishes PDE6αβ stability and enzymatic activity in vivo (PMID:11853759). PDE6G is essential for rod photoreceptor survival, as Pde6g-null mice undergo rapid rod degeneration followed by retinal remodeling (PMID:37363133), and a homozygous splice-site mutation in PDE6G causes autosomal recessive early-onset retinitis pigmentosa in humans (PMID:20655036). Transcriptionally, Pde6g expression is regulated by a ZNF124–MSX2 axis in the retina (PMID:41708596).

Mechanistic history

Synthesis pass · year-by-year structured walk · 9 steps
  1. 1990 High

    Cloning the human PDE6G cDNA established the molecular identity of the rod PDE6 inhibitory γ-subunit as an 87-amino-acid retina-specific protein, providing the sequence foundation for all subsequent structure–function work.

    Evidence cDNA cloning, sequencing, and Northern blot in human retina with chromosomal mapping

    PMID:2161380

    Open questions at the time
    • No structural information on how PDE6γ contacts the catalytic subunits
    • Functional domains not yet mapped
  2. 2001 High

    Transgenic complementation experiments in Pde6g-null mice resolved which PDE6γ residues control specific phases of phototransduction: Tyr84 is required for transducin-mediated PDE activation, while the W70A allele and other mutations produce a phenotypic spectrum from stationary night blindness to progressive degeneration.

    Evidence Transgenic Y84G and W70A complementation in Pde6g knockout mice with ERG and PDE activation assays

    PMID:11157892 PMID:11171042

    Open questions at the time
    • Atomic-resolution contacts between PDE6γ and transducin-α remain undefined
    • How PDE6γ mutations differentially trigger degeneration vs. stationary phenotypes is unclear
  3. 2002 High

    Deletion of the last 7 C-terminal residues demonstrated that this domain is indispensable for PDE6αβ catalytic subunit stability, linking PDE6γ to holoenzyme assembly beyond its inhibitory role, and extraretinal PDE6G expression was documented in lung.

    Evidence Del7C transgene rescue failure in knockout mice (Western blot, PDE activity); RT-PCR and Western blot in Pde6g-/- lung tissue

    PMID:11853759 PMID:11944991

    Open questions at the time
    • Whether PDE6γ has a direct signaling role in lung remains mechanistically unresolved
    • Chaperone or assembly pathway for PDE6 holoenzyme unknown
  4. 2010 High

    Identification of a homozygous PDE6G splice-site mutation in a human family established PDE6G as a retinitis pigmentosa disease gene, translating the mouse loss-of-function phenotype to human Mendelian disease.

    Evidence Homozygosity mapping, Sanger sequencing, in vitro splicing assay, ERG, and OCT in consanguineous family

    PMID:20655036

    Open questions at the time
    • Only one family reported; allelic spectrum in human RP not yet defined
    • Genotype–phenotype correlation across different PDE6G mutations in humans unknown
  5. 2011 High

    Single-cell electrophysiology of Ile86Ter mutant rods revealed that Ile86/Ile87 are specifically required for PDE6γ-mediated inhibition of basal PDE6 activity in the dark, resolving which C-terminal residues set the dark current and response kinetics.

    Evidence Suction-electrode recordings, ERG, and IBMX pharmacology in transgenic Ile86Ter rescue mice

    PMID:21616145 PMID:21920434

    Open questions at the time
    • How Ile86/87 engage the PDE6 catalytic pocket at the structural level is unresolved
    • In vivo dispensability of Asn74 contrasts with in vitro predictions — basis of this discrepancy unexplained
  6. 2015 Medium

    Detection of PDE6G protein in cone photoreceptors of Pde6h-null mice demonstrated that the rod γ-subunit can substitute for the cone-specific inhibitory subunit PDE6H, establishing functional interchangeability between PDE6 inhibitory subunit isoforms.

    Evidence Immunohistochemistry and ERG in Pde6h knockout mice

    PMID:25739440

    Open questions at the time
    • Whether PDE6G fully recapitulates PDE6H function in cones is not quantitatively established
    • Mechanism directing PDE6G to cones in absence of PDE6H unknown
  7. 2018 Medium

    Conditional ARL13B knockout showed that ARL13B is required for proper outer-segment localization of PDE6 (including PDE6G), linking ciliary trafficking machinery to PDE6 holoenzyme delivery.

    Evidence Inducible Pde6g-CreERT2-driven ARL13B knockout, immunofluorescence, and ERG in mature rods

    PMID:30573647

    Open questions at the time
    • Whether ARL13B acts directly on prenylated PDE6 subunits or through an intermediate is unknown
    • Other trafficking factors for PDE6 outer-segment delivery not identified
  8. 2023 Medium

    Comprehensive time-course analysis of Pde6g-null retinas documented that rod loss is nearly complete by postnatal day 16 and is followed by secondary inner retinal remodeling, vascular degeneration, and RPE abnormalities, defining the full degenerative cascade downstream of PDE6G loss.

    Evidence Multi-timepoint immunofluorescence, immunoblot, flat-mount, and acellular capillary quantification in Pde6g-/- mice

    PMID:37363133

    Open questions at the time
    • Molecular trigger of photoreceptor death (Ca²⁺ overload vs. cGMP toxicity) not distinguished
    • Whether secondary changes are treatable independently of rod rescue is unexplored
  9. 2026 Medium

    CUT&Tag and ChIP-exo in retina-specific knockouts revealed that ZNF124 controls MSX2 transcription, and MSX2 in turn drives Pde6g expression, establishing the first defined transcriptional regulatory cascade for Pde6g.

    Evidence CUT&Tag, ChIP-exo, RNA-seq in Gm20541 and Msx2 retinal knockout mice

    PMID:41708596

    Open questions at the time
    • Whether MSX2 binds the Pde6g promoter directly or acts through intermediates is not resolved
    • Other transcription factors regulating Pde6g (e.g., CRX, NRL) and their relationship to this axis are not addressed

Open questions

Synthesis pass · forward-looking unresolved questions
  • A high-resolution structural model of PDE6γ bound to the PDE6αβ catalytic core and to transducin-α, explaining how individual γ-subunit residues mediate inhibition and activation coupling, remains unavailable.
  • No cryo-EM or crystal structure of the full PDE6αβγ₂ holoenzyme with bound transducin
  • Quantitative kinetic model reconciling in vitro and in vivo mutagenesis results is lacking
  • Gene therapy or pharmacological rescue of PDE6G-associated RP has not been demonstrated

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0098772 molecular function regulator activity 4
Localization
GO:0005886 plasma membrane 2 GO:0005929 cilium 1
Pathway
R-HSA-9709957 Sensory Perception 4 R-HSA-162582 Signal Transduction 3
Partners
ARL13BGNAT1PDE6APDE6BPDE6H
Complex memberships
Rod PDE6 holoenzyme (PDE6αβγ₂)

Evidence

Reading pass · 16 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
1990 PDE6G encodes the inhibitory gamma subunit of rod cGMP-phosphodiesterase; the human cDNA was cloned from retina and shown to encode a 87-amino-acid protein highly conserved across bovine, mouse, and human, with the mRNA (~1.0 kb) detected specifically in rod photoreceptor-containing retinas; the gene was mapped to human chromosome 17. cDNA cloning, sequencing, Northern blotting, somatic cell hybrid mapping Gene High 2161380
2002 The carboxyl-terminal domain of PDE6γ is required to support PDE catalytic (PDEαβ) subunit stability and activity in vivo: a transgene encoding PDEγ lacking the last 7 C-terminal amino acids (Del7C) failed to complement Pdeg knockout mice, resulting in low PDE activity and reduced PDEα and PDEβ protein content, demonstrating the C-terminus is needed for maintaining phosphodiesterase activity and rod photoreceptor survival. Transgenic rescue experiment in Pdeg(tm1)/Pdeg(tm1) knockout mice, PDE activity assay, Western blot Vision research High 11853759
2001 Tyr84 of PDE6γ is required for full transducin-mediated PDE activation: the Y84G mutant transgene rescued photoreceptor survival in Pdeg knockout mice but caused a ~10-fold reduction in ERG a-wave amplitude and significantly reduced rate of PDE activation by transducin, demonstrating that Y84 contributes to transducin-dependent regulation of the PDE6 catalytic core in vivo. Transgenic complementation in Pdeg(tm1)/Pdeg(tm1) mice, ERG, in vivo PDE activation assay The Biochemical journal High 11171042
2011 The Ile86 and Ile87 residues at the extreme C-terminus of PDE6γ are required for normal inhibition of PDE6 catalytic (αβ) activity in vivo: ILE86TER rods showed decreased rate of photoresponse activation, decreased rate of decay, and higher spontaneous (dark) PDE6 activity, consistent with reduced inhibitory control by PDE6γ over PDE6αβ. Transgenic rescue in Pde6g(tm1)/Pde6g(tm1) mice, suction-electrode recordings, ERG, IBMX pharmacology Cellular signalling High 21920434
2011 The Asn74 residue of PDE6γ, which in vitro assays predicted to reduce inhibition of PDE6αβ, does not significantly alter basal PDE6 activity, circulating current, or light-response kinetics in vivo: N74A transgenic rods showed no increased dark PDE6 activity or light-adapted phenotype, indicating that in vivo regulation by PDE6γ is more dynamic and context-dependent than cell-free assays predicted. Transgenic complementation in Pde6g(tm1)/Pde6g(tm1) mice, ERG, suction-electrode recordings, in vitro PDE activity assay on purified mutant PDE Cellular signalling High 21616145
2003 Different alleles of Pdeg (Pdeg(tm), Del7C, Y84G, W70A) produce a spectrum of rod photoreceptor phenotypes ranging from stationary night blindness to progressive retinal degeneration, establishing allelic heterogeneity at the PDE6γ locus and linking specific PDE6γ structural domains to distinct phases (activation and deactivation) of phototransduction. Morphological and electrophysiological analysis of multiple Pdeg allele transgenic/knockout mouse lines Frontiers in bioscience Medium 12700134
2008 PDE6A expression is essential for the stability and normal expression of PDE6B and PDE6G: in a canine PDE6A-mutant model, Western blot showed that retinas lacking PDE6A protein also lacked PDE6B and PDE6G proteins, and had no PDE6 enzymatic activity, demonstrating that PDE6A is required for assembly/stability of the entire PDE6 holoenzyme including the γ subunit. Western blot, PDE6 enzymatic activity assay, immunohistochemistry in PDE6A-mutant dog retinas Investigative ophthalmology & visual science Medium 18775863
2010 A homozygous splice-site mutation (c.187+1G>T) in PDE6G causes autosomal recessive early-onset retinitis pigmentosa in humans: in vitro splicing assay demonstrated that the mutation leads to incorrect splicing, confirming that PDE6G and its γ subunit function are required for normal rod PDE6 activity and photoreceptor maintenance in humans. Homozygosity mapping, sequencing, in vitro splicing assay, ERG, funduscopy, OCT American journal of human genetics High 20655036
2001 Sildenafil (a PDE inhibitor) causes a reversible, dose-dependent reduction in ERG a- and b-wave amplitudes specifically in heterozygous Pde6g knockout mice but not in wild-type mice, demonstrating that PDE6G γ-subunit dosage modulates retinal sensitivity to PDE inhibition and that PDE6 activity is rate-limiting for normal rod phototransduction. ERG in PDEG(tm1)/+ heterozygous mice after systemic sildenafil administration Investigative ophthalmology & visual science Medium 11157892
2002 PDE6G (rod γ-subunit) transcripts and protein are expressed in non-retinal tissues including mouse lung, where rod and cone PDE6 γ-subunit isoforms (PDE6G and PDE6H) are present in membrane fractions; Pde6g-/- lung showed substantially reduced p14 immunostaining, linking PDE6G to regulation of p42/p44 MAPK signaling in lung. RT-PCR, Western blot with subunit-specific antibodies, immunostaining of Pde6g-/- vs. wild-type lung membranes Genomics Medium 11944991
2015 In Pde6h-/- (cone γ-subunit knockout) mice, rod PDE6G protein was detected in cone photoreceptors, indicating that PDE6G can functionally substitute for the cone-specific inhibitory subunit PDE6H within cones, revealing cross-species differences in subunit specificity. Pde6h knockout mouse generation, immunohistochemistry, ERG The Journal of biological chemistry Medium 25739440
2012 Rod phototransduction signaling mediated through PDE6G contributes to vigabatrin-induced retinal toxicity: Pde6g mutant mice showed significantly reduced retinal toxicity from vigabatrin treatment compared to controls, placing PDE6G-dependent rod signaling in the pathway that mediates this drug-induced photoreceptor damage. Vigabatrin treatment of Pde6g mutant mice, retinal structural analysis, comparison with Gnat2 mutants PloS one Medium 22970106
2018 ARL13B is required for proper localization of PDE6 (prenylated phosphodiesterase-6, which includes PDE6G) in rod photoreceptor outer segments: conditional knockout of ARL13B in mature rods caused mislocalization of PDE6 prior to loss of photoresponse, establishing ARL13B as a trafficking regulator for PDE6 in the photoreceptor cilium. Inducible conditional knockout (Pde6g-CreERT2) of ARL13B, immunofluorescence, ERG The Journal of neuroscience Medium 30573647
2023 Pde6g-/- mice exhibit early-onset, rapid rod photoreceptor degeneration (majority of rods lost by postnatal day 16), followed by retinal remodeling including inner neuron changes, Müller glia activation, retinal vascular degradation, and RPE structural abnormalities, confirming the essential role of PDE6G γ-subunit in maintaining PDE6 activity and rod photoreceptor survival. Immunofluorescence, immunoblot, retinal flat-mount, trypsin digest/acellular capillary quantification in Pde6g-/- mice at multiple time points Ophthalmology science Medium 37363133
2021 MALAT1 acts as a competing endogenous RNA (ceRNA) that sponges miR-378a-3p to upregulate PDE6G expression in retinal microvascular endothelial cells under high glucose conditions, promoting cell proliferation and inhibiting apoptosis; the MALAT1/miR-378a-3p/PDE6G axis was validated by dual-luciferase reporter, RIP, and RNA pull-down assays. Dual-luciferase reporter assay, RIP assay, RNA pull-down, siRNA knockdown, overexpression, CCK-8 proliferation assay Archives of physiology and biochemistry Low 34674599
2026 ZNF124 regulates Pde6g expression through a transcriptional axis: ZNF124 controls MSX2 transcription by binding its promoter, and MSX2 in turn controls the expression of Pde6g (along with Rs1 and Pdc) in the retina; loss of Gm20541 (ZNF124 homolog) or Msx2 in mouse retina leads to progressive rod degeneration and reduced Pde6g expression. CUT&Tag, ChIP-exo, RNA-seq in retina-specific knockout mice; integrated transcriptomic analysis Cell death & disease Medium 41708596

Source papers

Stage 0 corpus · 53 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2010 Autosomal-recessive early-onset retinitis pigmentosa caused by a mutation in PDE6G, the gene encoding the gamma subunit of rod cGMP phosphodiesterase. American journal of human genetics 69 20655036
2018 Genome-wide association study of milk fatty acid composition in Italian Simmental and Italian Holstein cows using single nucleotide polymorphism arrays. Journal of dairy science 62 30243637
2002 Expressed sequence tag analysis of human retina for the NEIBank Project: retbindin, an abundant, novel retinal cDNA and alternative splicing of other retina-preferred gene transcripts. Molecular vision 53 12107411
2008 Characterization of a canine model of autosomal recessive retinitis pigmentosa due to a PDE6A mutation. Investigative ophthalmology & visual science 49 18775863
2016 Evolution and expression of the phosphodiesterase 6 genes unveils vertebrate novelty to control photosensitivity. BMC evolutionary biology 44 27296292
2018 ARL13B, a Joubert Syndrome-Associated Protein, Is Critical for Retinogenesis and Elaboration of Mouse Photoreceptor Outer Segments. The Journal of neuroscience : the official journal of the Society for Neuroscience 42 30573647
2001 Sildenafil-mediated reduction in retinal function in heterozygous mice lacking the gamma-subunit of phosphodiesterase. Investigative ophthalmology & visual science 40 11157892
2011 Putative essential and core-essential genes in Mycoplasma genomes. Scientific reports 37 22355572
2019 A commonly occurring genetic variant within the NPLOC4-TSPAN10-PDE6G gene cluster is associated with the risk of strabismus. Human genetics 35 31073882
1990 Isolation and characterization of cDNA encoding the gamma-subunit of cGMP phosphodiesterase in human retina. Gene 35 2161380
2018 Gene set enrichment analysis of SNP data in dairy and beef cattle with bovine respiratory disease. Animal genetics 29 30229962
2015 Targeted ablation of the Pde6h gene in mice reveals cross-species differences in cone and rod phototransduction protein isoform inventory. The Journal of biological chemistry 27 25739440
2013 Expression of phosphodiesterase 6 (PDE6) in human breast cancer cells. SpringerPlus 25 24683528
1994 Evaluation of the gene encoding the gamma subunit of rod phosphodiesterase in retinitis pigmentosa. Investigative ophthalmology & visual science 23 8125719
1989 The gene for the gamma-subunit of retinal cGMP-phosphodiesterase is on mouse chromosome 11. Experimental eye research 23 2538340
2010 Phosphodiesterase 6 subunits are expressed and altered in idiopathic pulmonary fibrosis. Respiratory research 21 20979602
2012 Vigabatrin-induced retinal toxicity is partially mediated by signaling in rod and cone photoreceptors. PloS one 19 22970106
2005 A cohabitation challenge to compare the efficacies of vaccines for bacterial kidney disease (BKD) in chinook salmon Oncorhynchus tshawytscha. Diseases of aquatic organisms 17 15819430
2002 The positive role of the carboxyl terminus of the gamma subunit of retinal cGMP-phosphodiesterase in maintaining phosphodiesterase activity in vivo. Vision research 17 11853759
1997 Retinitis pigmentosa locus on 17q (RP17): fine localization to 17q22 and exclusion of the PDEG and TIMP2 genes. Human genetics 17 9385361
2001 In vivo studies of the gamma subunit of retinal cGMP-phophodiesterase with a substitution of tyrosine-84. The Biochemical journal 14 11171042
2021 lncRNA MALAT1 promotes diabetic retinopathy by upregulating PDE6G via miR-378a-3p. Archives of physiology and biochemistry 13 34674599
2002 The identification of the inhibitory gamma-subunits of the type 6 retinal cyclic guanosine monophosphate phosphodiesterase in non-retinal tissues: differential processing of mRNA transcripts. Genomics 13 11944991
2021 Differential expression analysis using a model-based gene clustering algorithm for RNA-seq data. BMC bioinformatics 12 34670485
2003 Stationary night blindness or progressive retinal degeneration in mice carrying different alleles of PDE gamma. Frontiers in bioscience : a journal and virtual library 11 12700134
2018 Lateralized expression of left-right axis formation genes is shared by adult brains of lefty and righty scale-eating cichlids. Comparative biochemistry and physiology. Part D, Genomics & proteomics 10 30007273
1999 Evaluation of cGMP-phosphodiesterase (PDE) subunits for causal association with rod-cone dysplasia 2 (rcd2), a canine model of abnormal retinal cGMP metabolism. Experimental eye research 10 10504278
1992 Syntenic assignments of visual transduction genes in cattle. Genomics 10 1330890
2016 Transcriptomic responses in the oral cavity of F344 rats and B6C3F1 mice following exposure to Cr(VI): Implications for risk assessment. Environmental and molecular mutagenesis 9 27859739
2015 The Biosynthesis of UDP-D-QuiNAc in Bacillus cereus ATCC 14579. PloS one 9 26207987
2011 Effect of the ILE86TER mutation in the γ subunit of cGMP phosphodiesterase (PDE6) on rod photoreceptor signaling. Cellular signalling 8 21920434
2023 A New Preclinical Model of Retinitis Pigmentosa Due to Pde6g Deficiency. Ophthalmology science 7 37363133
2022 A Cross-Tissue Transcriptome-Wide Association Study Identifies Novel Susceptibility Genes for Juvenile Idiopathic Arthritis in Asia and Europe. Frontiers in immunology 7 35967305
2007 Association of the Asn306Ser variant of the SP4 transcription factor and an intronic variant in the beta-subunit of transducin with digenic disease. Molecular vision 7 17356515
2024 Deficiency of the ribosomal protein uS10 (RPS20) reorganizes human cells translatome according to the abundance, CDS length and GC content of mRNAs. Open biology 6 38290548
2024 Deciphering Müller cell heterogeneity signatures in diabetic retinopathy across species: an integrative single-cell analysis. European journal of medical research 6 38698486
2011 Function of the asparagine 74 residue of the inhibitory γ-subunit of retinal rod cGMP-phophodiesterase (PDE) in vivo. Cellular signalling 5 21616145
2003 Analysis of PDE6D and PDE6G genes for generalised progressive retinal atrophy (gPRA) mutations in dogs. Genetics, selection, evolution : GSE 5 12927076
2023 Transcriptome-wide association study identifies new susceptibility genes for degenerative cervical spondylosis. Bone & joint research 4 36660900
2016 Biosynthesis of three N-acetylaminosugar-conjugated flavonoids using engineered Escherichia coli. Microbial cell factories 4 27776529
2002 Autosomal dominant retinal dystrophy (Rdy) in Abyssinian cats: exclusion of PDE6G and ROM1 and likely exclusion of Rhodopsin as candidate genes. Animal genetics 4 12464018
2025 Orthogonal RNA-regulated destabilization domains for three-color RNA imaging with minimal RNA perturbation. Nature methods 3 41407926
2024 Paternal-effect-genes revealed through sperm cryopreservation in Perca fluviatilis. Scientific reports 3 38493223
2022 Integrative RNA-seq and ATAC-seq analyses of phosphodiesterase 6 mutation-induced retinitis pigmentosa. International ophthalmology 3 35147831
2023 Identification of hub genes correlated with diabetic retinopathy via bioinformatics methods. European review for medical and pharmacological sciences 2 37318461
2024 Analysis of PDE6G mutations in a patient with retinitis pigmentosa. BMC ophthalmology 1 39160471
2023 Transcriptome-wide association study identifies new susceptibility genes and pathways for spondyloarthritis. Journal of orthopaedic surgery and research 1 37667381
2013 Selection of Phototransduction Genes in Homo sapiens. Investigative ophthalmology & visual science 1 23868983
2026 Unveiling ZNF124 as a novel determinant in neurodegeneration: orchestration of photoreceptor homeostasis through MSX2 transcriptional regulation. Cell death & disease 0 41708596
2026 Post-thaw storage of sperm as a tool towards revealing paternal-effect-associated genes in Eurasian perch, Perca fluviatilis. BMC genomics 0 41721232
2025 Retinitis Pigmentosa (Non-syndromic). Advances in experimental medicine and biology 0 40736827
2024 Cross-species single-cell landscapes identify the pathogenic gene characteristics of inherited retinal diseases. Frontiers in genetics 0 39055259
2024 Analysis of candidate variants in a Chinese family with monozygotic twins with keratoconus: a case report. Ophthalmic genetics 0 39544142